Quick Read – MSOS delivers single-ticker U.S. cannabis exposure through total-return swaps, but only ~15% of its assets are held in direct cannabis equities. – Dan Ahrens describes MSOS as a federal policy bet, not a fundamentals play.
The fund is up 111% in one year but down 87% over five. – Curaleaf alone represents ~25% of MSOS assets, making the fund’s 27-position diversification far less protective than it appears. – Owning individual U.S. cannabis operators means wrestling with OTC-listed tickers, thin liquidity, and a patchwork of state licenses that most brokerage screeners barely index
The AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) exists to collapse that mess into one ticker. For a retirement-skewing investor who wants a small speculative dose of the U.S. multi-state operator (MSO) trade without opening a special OTC account, MSOS is the closest thing to a turnkey vehicle. The catch is that the plumbing inside MSOS is more exotic than a typical sector ETF, and the ride has been brutal for anyone who bought it as a long-term hold.
What MSOS Actually Owns Because cannabis remains federally illegal, MSOS cannot hold shares of U.S. plant-touching operators directly. Instead, the fund uses total-return swaps with counterparties, including Nomura and Cantor Fitzgerald, to replicate the economics of owning those stocks. The direct equity book is smaller than most holders realize: roughly 15% of net assets is in cannabis equities, with the remainder in short-term Treasury instruments and derivative exposure.